Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Tue, 23 Jul 2019 04:20:18 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190708155152_14140605 Mon, 08 Jul 2019 15:51:52 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190708155152_14140605 <![CDATA[RNS press release - Clinical Update ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190708070006_14139213 Mon, 08 Jul 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190708070006_14139213 <![CDATA[RNS press release - Change of Adviser ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190701070010_14130324 Mon, 01 Jul 2019 07:00:10 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190701070010_14130324 <![CDATA[RNS press release - Result of AGM ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190620103846_14118282 Thu, 20 Jun 2019 10:38:46 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190620103846_14118282 <![CDATA[RNS press release - 4D presents MRx0518 combination study at ASCO ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190603070011_14095209 Mon, 03 Jun 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190603070011_14095209 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190530070008_14091626 Thu, 30 May 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190530070008_14091626 <![CDATA[RNS press release - Annual Report and Notice of AGM ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190528145035_14089537 Tue, 28 May 2019 14:50:35 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190528145035_14089537 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190523070009_14084402 Thu, 23 May 2019 07:00:09 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190523070009_14084402 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190522070006_14082715 Wed, 22 May 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190522070006_14082715 <![CDATA[RNS press release - Final Results ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190521070013_14080943 Tue, 21 May 2019 07:00:13 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190521070013_14080943 <![CDATA[RNS press release - 4D Presents Phase Ib Clinical Data on Thetanix® ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190516070006_14075870 Thu, 16 May 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190516070006_14075870 <![CDATA[RNS press release - Participation in Conferences ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190513080001_14071130 Mon, 13 May 2019 08:00:01 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190513080001_14071130 <![CDATA[RNS press release - Clinical Update - MRx0518 oncology programmes ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190429070020_14054602 Mon, 29 Apr 2019 07:00:20 +0100 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190429070020_14054602 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190314070020_14001563 Thu, 14 Mar 2019 07:00:20 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190314070020_14001563 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190313090801_14000449 Wed, 13 Mar 2019 09:08:01 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190313090801_14000449 <![CDATA[RNS press release - Participation in Microbiome Conference ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190308070005_13994858 Fri, 08 Mar 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190308070005_13994858 <![CDATA[RNS press release - Publication of data in connection with MRx0518 ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190129070009_13949565 Tue, 29 Jan 2019 07:00:09 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190129070009_13949565 <![CDATA[RNS press release - Appointment of independent Non-Executive Directors ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190108070005_13926645 Tue, 08 Jan 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190108070005_13926645 <![CDATA[RNS press release - Collaboration with MD Anderson Cancer Center ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190107070006_13925041 Mon, 07 Jan 2019 07:00:06 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20190107070006_13925041 <![CDATA[RNS press release - Director/PDMR Shareholding ]]> https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20181221070003_13912391 Fri, 21 Dec 2018 07:00:03 +0000 https://www.proactiveinvestors.co.uk/LON:DDDD/4D-Pharma/rns/LSE20181221070003_13912391